Company page

Savara, Inc.

Savara, Inc. is a public company traded under the ticker SVRA in the American market. With a market capitalization of approximately $1.13 billion, Savara focuses on developing innovative treatments for patients with rare respiratory diseases. The company is committed to advancing its pipeline of therapies to improve patient outcomes.